Key facts
- This page summarizes Melissa B. Epperly's Form 3 filing for Nautilus Biotechnology, Inc. (NAUT).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jun 2021, 21:41.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the "Plan")) through each vesting date, one thirty-sixth (1/36th) of the shares subject to the Option shall vest each month over the thirty-six (36) months following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 31, 2021.
SEC remarks
Exhibit 24: Power of Attorney